Platelet Function and Reactivity Tests

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Platelet Function and Reactivity Tests trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingEarly Phase 1

NCT06933056

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

This study will identify the potential benefits of regulating platelet activation with sotagliflozin compared to other FDA-approved drugs known to limit platele…

United States20 participantsStarted 2025-09-02

Treatment: Sotagliflozin (SOTA) followed by 3 drugs in a random order, Aspirin followed by 3 drugs in a random order

All recent trials (8 shown)

Not Yet RecruitingPhase 4

NCT07203846

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

The FLORA-ACS study aims to evaluate the relationship between dysbiosis and high platelet reactivity during treatment with ticagrelor in patients with a history…

Poland50 participantsStarted 2026-01-01

Treatment: Rifaximin

CompletedPhase 4

NCT04001894

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor reduces thrombotic events in patients with coronary artery disease, but these benefits come…

China50 participantsStarted 2019-07-02

Treatment: Ticagrelor 90mg, Clopidogrel 75mg

Platelet Function and Reactivity Tests

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

All recent trials (8 shown)

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

All recent trials (8 shown)

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagent…

Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy

Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery

Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity

Platelet Reactivity in Stent Thrombosis Patients